Cargando…
Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deplo...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133815/ https://www.ncbi.nlm.nih.gov/pubmed/27809247 http://dx.doi.org/10.3390/ijms17111814 |
_version_ | 1782471344660676608 |
---|---|
author | Tavel, Laurette Fontana, Francesca Garcia Manteiga, Josè Manuel Mari, Silvia Mariani, Elisabetta Caneva, Enrico Sitia, Roberto Camnasio, Francesco Marcatti, Magda Cenci, Simone Musco, Giovanna |
author_facet | Tavel, Laurette Fontana, Francesca Garcia Manteiga, Josè Manuel Mari, Silvia Mariani, Elisabetta Caneva, Enrico Sitia, Roberto Camnasio, Francesco Marcatti, Magda Cenci, Simone Musco, Giovanna |
author_sort | Tavel, Laurette |
collection | PubMed |
description | Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deployed unbiased (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) metabolomics to analyze multiple biopsy specimens of osteolytic lesions from one case of pathological fracture caused by MM. Multivariate analyses on normalized metabolite peak integrals allowed clusterization of samples in accordance with a posteriori histological findings. We investigated the relationship between morphological and NMR features by merging morphological data and metabolite profiling into a single correlation matrix. Data-merging addressed tissue heterogeneity, and greatly facilitated the mapping of lesions and nearby healthy tissues. Our proof-of-principle study reveals integrated metabolomics and histomorphology as a promising approach for the targeted study of osteolytic lesions. |
format | Online Article Text |
id | pubmed-5133815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-51338152016-12-12 Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics Tavel, Laurette Fontana, Francesca Garcia Manteiga, Josè Manuel Mari, Silvia Mariani, Elisabetta Caneva, Enrico Sitia, Roberto Camnasio, Francesco Marcatti, Magda Cenci, Simone Musco, Giovanna Int J Mol Sci Article Multiple myeloma (MM) is a malignancy of plasma cells characterized by multifocal osteolytic bone lesions. Macroscopic and genetic heterogeneity has been documented within MM lesions. Understanding the bases of such heterogeneity may unveil relevant features of MM pathobiology. To this aim, we deployed unbiased (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) metabolomics to analyze multiple biopsy specimens of osteolytic lesions from one case of pathological fracture caused by MM. Multivariate analyses on normalized metabolite peak integrals allowed clusterization of samples in accordance with a posteriori histological findings. We investigated the relationship between morphological and NMR features by merging morphological data and metabolite profiling into a single correlation matrix. Data-merging addressed tissue heterogeneity, and greatly facilitated the mapping of lesions and nearby healthy tissues. Our proof-of-principle study reveals integrated metabolomics and histomorphology as a promising approach for the targeted study of osteolytic lesions. MDPI 2016-10-31 /pmc/articles/PMC5133815/ /pubmed/27809247 http://dx.doi.org/10.3390/ijms17111814 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tavel, Laurette Fontana, Francesca Garcia Manteiga, Josè Manuel Mari, Silvia Mariani, Elisabetta Caneva, Enrico Sitia, Roberto Camnasio, Francesco Marcatti, Magda Cenci, Simone Musco, Giovanna Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title_full | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title_fullStr | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title_full_unstemmed | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title_short | Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics |
title_sort | assessing heterogeneity of osteolytic lesions in multiple myeloma by (1)h hr-mas nmr metabolomics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133815/ https://www.ncbi.nlm.nih.gov/pubmed/27809247 http://dx.doi.org/10.3390/ijms17111814 |
work_keys_str_mv | AT tavellaurette assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT fontanafrancesca assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT garciamanteigajosemanuel assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT marisilvia assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT marianielisabetta assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT canevaenrico assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT sitiaroberto assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT camnasiofrancesco assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT marcattimagda assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT cencisimone assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics AT muscogiovanna assessingheterogeneityofosteolyticlesionsinmultiplemyelomaby1hhrmasnmrmetabolomics |